Literature DB >> 278638

Therapy of acute myelogeneous leukemia.

E J Freireich, M J Keating, E A Gehan, K B McCredie, G P Bodey, T Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 278638     DOI： 10.1002/1097-0142(197808)42:2+<874::aid-cncr2820420709>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Authors:  H M Kantarjian; B Barlogie; M J Keating; R R Hall; T L Smith; K B McCredie; E J Freireich
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

2.  Long survival in acute myelogenous leukaemia: an international collaborative study.

Authors:  J A Whittaker; P Reizenstein; S T Callender; G G Cornwell; I W Delamore; R P Gale; M Gobbi; P Jacobs; B Lantz; A T Maiolo; J K Rees; E J Van Slyck; H V Van
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-28

Review 3.  Advances in the management of adult acute myelogenous leukaemia.

Authors:  J A Whittaker
Journal:  Br Med J       Date:  1980-10-11

4.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

5.  Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.

Authors:  S Seeber; H Loth
Journal:  Blut       Date:  1981-06

6.  [Bone marrow transplantation for relapsed, acute leukaemia (author's transl)].

Authors:  H J Kolb; C Bender-Götze; E D Albert; R Haas; G Janka
Journal:  Klin Wochenschr       Date:  1981-03-16

7.  Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.

Authors:  S R Zuhrie; R Harris; C B Freeman; J E MacIver; C G Geary; I W Delamore; J A Tooth
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.